Company / Operating Income per Share
Tango Therapeutics, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.03
FY2025
5-year range
-$1.42 / -$0.67
FY2021-FY2025
Trend
+27.5%
vs FY2024
Sector context
#88 of 201
Health Care
What the data says
At $-1.03, Tango Therapeutics, Inc.'s operating income per share ranks #88 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $-1.03.
Based on SEC 10-K filings.
-1.03 in FY2025.
Improved from $-1.29 to $-1.03 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#88 of 201 in Health CareTop 44% of 201This company -$1.03 Sector average -$28.56
▼
+96.4% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 27.5% year-over-year.
- Ranks #88 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.03 | +27.5% |
| FY2024 | -$1.42 | -10.0% |
| FY2023 | -$1.29 | -94.6% |
| FY2022 | -$0.67 | +48.6% |
| FY2021 | -$1.29 | +20.9% |
| FY2020 | -$1.63 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026